EGFR and non-small cell lung carcinoma: Among the other techniques available for EGFR mutation detection in cfDNA18, the commercial Cobas EGFR mutation assay v2 kit is one of the most quantitative PCR methods investigated and the only FDA-approved companion diagnostic for the detection of exon 19 deletion, L858R and T790M mutations in plasma samples from NSCLC patients22.